Not exactly. Of course it's important that public institutions pay their bills and the only extortion method a private delivery company has is to cut supplies. I find it surprising though that it's taken Spain so long (in comparison with the Netherlands and Sweden) to make reforms in the systems for pharmaceutical subscription. In Sweden, for as long as I remember, it's been mandatory to prescribe the substance, not a brand name providing a substance, and the pharmacy has a duty to sell you the cheapeast generic brand. Basically this could have been, or is now actually because a new law is in place since august last year, a way of keeping costs down and manageable, instead of paying much money to IPR holders once the upkeep of those payments aren't strictly necessary.
Not exactly. Of course it's important that public institutions pay their bills and the only extortion method a private delivery company has is to cut supplies. I find it surprising though that it's taken Spain so long (in comparison with the Netherlands and Sweden) to make reforms in the systems for pharmaceutical subscription. In Sweden, for as long as I remember, it's been mandatory to prescribe the substance, not a brand name providing a substance, and the pharmacy has a duty to sell you the cheapeast generic brand. Basically this could have been, or is now actually because a new law is in place since august last year, a way of keeping costs down and manageable, instead of paying much money to IPR holders once the upkeep of those payments aren't strictly necessary.